The MYO16 gene, implicated in the development of Autism Spectrum Disorder (ASD), plays a crucial role in brain development and function. Variations or mutations in the MYO16 gene have been associated with an increased risk of ASD, a complex neurodevelopmental disorder characterized by challenges with social interaction, communication, and repetitive behaviors. Recognizing the genetic underpinnings of ASD can be pivotal for early diagnosis, personalized intervention, and management strategies for affected individuals.
DNA Labs UAE offers a specialized genetic test targeting the MYO16 gene to identify mutations that may contribute to ASD. This test is an invaluable tool for families with a history of autism or for individuals showing symptoms of ASD, providing them with a clearer understanding of their condition and guiding them towards appropriate support and treatment options.
The test, priced at 4400 AED, involves a simple, non-invasive procedure to collect a DNA sample, typically through a blood draw or a cheek swab. The sample is then analyzed in the laboratory using advanced genetic sequencing technologies to detect any mutations in the MYO16 gene. Results from the test can offer crucial insights into the genetic makeup of the individual, facilitating a more tailored approach to managing and treating ASD.
DNA Labs UAE ensures confidentiality and provides comprehensive support throughout the testing process, including pre-test counseling to understand the implications of the test and post-test counseling to interpret the results and discuss the next steps. This MYO16-related genetic test is a step forward in personalized medicine, offering hope and direction to individuals and families affected by Autism Spectrum Disorder.
The MXRA5 gene, also known as the Matrix-Remodeling Associated 5 gene, has been identified as a gene of interest in the study of Autism Spectrum Disorder (ASD). Research has suggested that variations in the MXRA5 gene may be linked to the development of ASD, making it a potential target for genetic testing. The MXRA5-related genetic test is designed to detect mutations or alterations in this specific gene that might be associated with an increased risk of ASD.
This test is particularly valuable for families with a history of ASD or for individuals who show symptoms related to autism spectrum conditions. By understanding the genetic makeup and potential risks, it can provide insights for early intervention strategies, personalized treatment plans, and support for affected individuals and their families.
DNA Labs UAE offers this specialized genetic test for MXRA5, providing a comprehensive analysis of the gene in question. The test is conducted in a state-of-the-art laboratory by experienced geneticists and clinicians who ensure accuracy and confidentiality. The cost of the MXRA5-related genetic test at DNA Labs UAE is 4400 AED. The price reflects the sophisticated technology and expertise required to analyze genetic information accurately.
Individuals or families interested in undergoing this genetic test can contact DNA Labs UAE to schedule an appointment. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory. Results are usually provided within a few weeks, accompanied by a detailed report and a consultation to discuss the findings and any recommended next steps.
The GRM7 gene, associated with the glutamate neurotransmitter system, plays a crucial role in various brain functions, including cognition, emotion, and sensory processing. Variations in this gene have been linked to several neuropsychiatric conditions, including Autism Spectrum Disorder (ASD), hyperactivity, and Bipolar Disorder. These conditions manifest through a wide range of symptoms, from social interaction challenges and repetitive behaviors in ASD to mood swings in Bipolar Disorder, and excessive activity in cases of hyperactivity.
To understand the genetic predisposition to these conditions, DNA Labs UAE offers a specialized genetic test targeting the GRM7 gene. This test is designed to identify specific mutations or variations within the GRM7 gene that may contribute to the development of ASD, hyperactivity, and Bipolar Disorder. By analyzing an individual's genetic makeup, this test can provide valuable insights into their risk of developing these conditions, enabling early intervention strategies and personalized treatment plans.
The test is conducted with a high level of accuracy and confidentiality, requiring a simple DNA sample obtained through a non-invasive method. The cost of the GRM7-related genetic test is 4400 AED, reflecting the comprehensive analysis and detailed report provided. This investment allows individuals and families to gain a deeper understanding of their genetic predispositions and to make informed decisions about their health and wellbeing.
The UBQLN2 gene is associated with a rare form of Amyotrophic Lateral Sclerosis (ALS) that can occur in both juvenile and adult-onset cases. This genetic condition is linked to the X chromosome and involves mutations in the UBQLN2 gene, which plays a critical role in protein degradation and homeostasis within cells. Mutations in this gene can lead to the accumulation of abnormal proteins, contributing to the progressive degeneration of motor neurons that is characteristic of ALS.
DNA Labs UAE offers a specialized genetic test designed to detect mutations in the UBQLN2 gene, aiding in the diagnosis of X-linked juvenile and adult-onset ALS. This test is crucial for individuals with a family history of ALS or early symptoms of the disease, as it can provide a definitive diagnosis and help in the planning of appropriate management and treatment strategies.
The test is priced at 4400 AED and involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the UBQLN2 gene. Results from this test can also offer valuable information for family planning and genetic counseling for affected families, providing insights into the risk of passing the condition on to future generations. DNA Labs UAE ensures confidentiality and accuracy in the testing process, offering support and guidance throughout the testing and post-test interpretation phases.
The TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism Dementia Complex Susceptibility Genetic Test is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to identify genetic mutations in the TRPM7 gene, which have been associated with an increased risk of developing a complex neurological condition encompassing amyotrophic lateral sclerosis (ALS), parkinsonism, and dementia. These conditions are characterized by progressive degeneration of nerve cells, leading to a wide range of symptoms including muscle weakness, movement disorders, and cognitive decline.
The test is conducted through a comprehensive analysis of the patient's DNA to detect any alterations in the TRPM7 gene that may predispose them to these neurodegenerative diseases. This information is crucial for individuals with a family history of these conditions, as it can provide valuable insights into their risk profile and help in making informed decisions about their health care and management.
The cost of the TRPM7 Gene Susceptibility Genetic Test at DNA Labs UAE is 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify and interpret genetic variations associated with these complex conditions. By choosing to undergo this test, patients gain access to personalized genetic information that can play a significant role in their health and well-being, offering a proactive approach to managing potential neurological health risks.
The "9-Sep Gene Amyotrophy Hereditary Neuralgic Genetic Test" is a specialized diagnostic procedure designed to identify genetic mutations associated with hereditary neuralgic amyotrophy (HNA), a rare condition that affects the peripheral nervous system. This condition is characterized by recurrent episodes of nerve pain and muscle weakness, primarily impacting the shoulders and arms. The test focuses on analyzing the 9-Sep gene, which has been closely linked to the development of this condition.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis for individuals suspected of having or at risk of developing hereditary neuralgic amyotrophy. By examining the specific genetic markers within the 9-Sep gene, the test can provide valuable insights into the patient's condition, aiding in the diagnosis and potentially guiding treatment options.
The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic variations associated with HNA. This investment can be invaluable for affected individuals and their families, offering a clearer understanding of the condition and facilitating more informed healthcare decisions.
The Chr. 15q11 Gene Angelman Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the chromosome 15q11-q13 region, which are responsible for Angelman Syndrome. Angelman Syndrome is a genetic disorder that primarily affects the nervous system, leading to developmental delays, problems with speech and balance, intellectual disability, and sometimes, seizures. This condition is often caused by deletions or other genetic abnormalities in the maternal copy of the 15q11-q13 region.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the lab for specific genetic changes associated with Angelman Syndrome. It is a critical tool for families seeking answers to developmental issues in their children, providing them with essential information for management and treatment strategies.
At DNA Labs UAE, the cost of the Chr. 15q11 Gene Angelman Syndrome Genetic Test is set at 3200 AED. The test is conducted with the utmost precision and care by experienced professionals, ensuring reliable and accurate results. DNA Labs UAE is equipped with state-of-the-art technology and follows stringent protocols to deliver high-quality genetic testing services.
The UBE3A Gene Angelman Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the UBE3A gene, which are closely linked to Angelman syndrome. Angelman syndrome is a genetic disorder that primarily affects the nervous system, leading to developmental delays, problems with speech and balance, intellectual disability, and sometimes, seizures. This condition is often caused by the loss of function of the UBE3A gene located on chromosome 15.
DNA Labs UAE utilizes advanced genetic testing techniques to analyze the UBE3A gene for any abnormalities that might indicate the presence of Angelman syndrome. This test is crucial for early diagnosis and intervention, which can significantly improve the quality of life for individuals with this condition. The cost of the UBE3A Gene Angelman Syndrome Genetic Test is 4400 AED, reflecting the sophisticated nature of the genetic analysis and the invaluable insights it provides to affected families. Early diagnosis through this test can lead to better management strategies and support for individuals with Angelman syndrome and their families.
The CDKL5 Gene Angelman-like Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the CDKL5 gene. These mutations are known to cause a rare genetic disorder that presents with symptoms similar to Angelman syndrome, including developmental delays, intellectual disabilities, and epilepsy. The test, which costs 4400 AED, involves analyzing the patient's DNA to detect abnormalities in the CDKL5 gene, providing crucial information for accurate diagnosis and management of the condition. This test is a critical step for families seeking answers to complex neurological symptoms, guiding them towards appropriate treatments and support services.
The MECP2 gene Angelman-like syndrome genetic test is a specialized diagnostic procedure aimed at identifying mutations in the MECP2 gene, which are associated with conditions resembling Angelman syndrome. Angelman-like syndromes are a group of neurodevelopmental disorders that share similar characteristics with Angelman syndrome but are caused by genetic abnormalities in different genes, including MECP2. Symptoms of these conditions can include developmental delays, speech impairments, seizures, and unique behaviors such as frequent laughter or smiling.
This test is particularly crucial for individuals showing symptoms of Angelman syndrome but without the typical genetic markers for that condition. By analyzing the MECP2 gene, healthcare professionals can accurately diagnose the presence of Angelman-like syndrome, enabling them to provide targeted interventions and support to patients and their families.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the MECP2 gene Angelman-like syndrome genetic test costs 4400 AED. The lab ensures precise and reliable results, thanks to its use of cutting-edge technology and adherence to stringent quality control measures. Opting for this test at DNA Labs UAE offers patients and healthcare providers a critical tool in the diagnosis and management of Angelman-like syndromes, paving the way for improved outcomes and quality of life for affected individuals.
